InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
62,150.10
(
2.07%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oldchemist4

Send PM Follow Ignore
Followers 2
Posts 198
Boards Moderated 0
Alias Born 12/16/2012

oldchemist4

Re: adreamer post# 30953

Monday, 06/03/2013 9:33:53 AM

Monday, June 03, 2013 9:33:53 AM

Post# of 80490
Because they are very early in their trial(s) but still wanted to get something out at ASCO, that's why.

Just from the press release, I would say that the clvs drug is different, but not better. The drug is noted as an irreversible inhibitor - very interesting - and with no maximum tolerated dose found yet. But the anemia AE is notable - no explanation, but that is not an AE to dismiss.

Still, it is competition.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up